Examines K⁺ secretion in mice with PHAII, indicating altered renal transport mechanisms.
Pseudohypoaldosteronism type II (PHAII), also known as Gordon syndrome, is an autosomal-dominant disorder caused by mutations in with-no-lysine kinase 4 (WNK4) and is characterized by increased renal NaCl reabsorption and impaired K⁺ secretion. We examined the relative contributions of renal outer medullary K⁺ (ROMK) channels and large-conductance Ca²⁺-activated K⁺ (BK; Maxi-K) channels to distal K⁺ secretion in wild-type (TgWnk4 WT ) and PHAII mutant (TgWnk4 PHAII ) mice. Renal clearance and stationery microperfusion techniques were used to assess urinary Na⁺ and K⁺ excretion and K⁺ secretion in the late distal tubule. Potassium secretion (JK) and the half-time to reach steady-state luminal K⁺ concentration (T₁/₂) were measured under control-K⁺ (CK) and high-K⁺ (HK) dietary conditions. Quantitative PCR revealed reduced ROMK expression, in TgWnk4 PHAII mice compared with wild-type mice. Micropuncture studies showed significantly reduced K⁺ secretion in the late distal tubule under CK conditions in TgWnk4 PHAII mice. Iberiotoxin had no effect on JK or T₁/₂ in either genotype under CK conditions. In contrast, HK feeding increased distal K⁺ secretion in both genotypes, and this increase was completely abolished by iberiotoxin. These findings indicate that impaired K⁺ secretion in TgWnk4 PHAII mice is due to reduced ROMK-mediated transport and is not compensated by Maxi-K channels under normal K⁺ intake. The TgWnk4 PHAII mutation does not impair HK-stimulated Maxi-K channel–mediated K⁺ secretion in the distal nephron.
No takes yet. Share an insight, caveat, or question.
Lessa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: